4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-037164
Options or other derivatives
- Chief Financial Officer acquired 16,961 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Vu Quan Anh Chief Financial Officer | 2025-12-02 | Grant or award · Stock Options | +7,135 | 7,135 | D: show line 1 in the form | |||||
| Vu Quan Anh Chief Financial Officer | 2025-12-02 | Grant or award · Restricted Stock Units | +9,826 | 9,826 | D: show line 2 in the form |
Loading xslF345X05/rdgdoc.xml…